|
The
drug-related AIDS epidemic in Connecticut |
Health
emergency
 |
Through
the end of 1998, some 6,200 Connecticut residents age 13 and over
had injection-related AIDS or had died from it. (1)
|
 |
Connecticut
has the fourth highest injection-related AIDS rate in the nation. (2)
|
 |
More
than three-quarters of all AIDS cases in Connecticut are
injection-related. (3)
|
Metro areas ranking among highest in the U.S.
 |
The
Hartford metro area ranks sixth in injection-related AIDS among
U.S. metro areas of over 500,000.
(The Hartford metro area is tied for sixth with the Baton
Rouge, Louisiana, metro area.) |
 |
The
New Haven-Bridgeport metro area ranks tenth. (4)
|
The
crisis among African Americans and Latinos
 |
Through
the end of 1998, some 2,900 African Americans and 1,800 Latinos
living in Connecticut had injection-related AIDS or had died from
it.
|
 |
The
rate of injection-related AIDS cases among blacks in Connecticut
is 19 times higher than the rate for whites.
The rate for Latinos is 15 times higher than the rate for
whites. (5)
|
Thousands
of all races at risk
 |
In
1996, in
the Hartford and New Haven metropolitan areas, there
were an estimated 58,000 who were at risk for HIV either because
they injected drugs or because they were the heterosexual partners
of persons who injected drugs. (6) |
Information
on the USA and other states
_________________
Footnotes
| (1) |
AIDS data are from a special tabulation from the Centers for Disease
Control. Injection-related
AIDS cases include persons in the following risk groups: persons who
inject drugs; men who have sex with men and inject drugs; and the
heterosexual partners of persons who inject drugs.
AIDS cases are rounded to the nearest hundred.
|
| (2) |
Injection-related AIDS rates per million for states were calculated
using injection-related AIDS cases among persons age 13 and over (the
3-year average for the years 1996-1998) divided by the 1997 population
age 13 and over. The 3-year
average was used to smooth out any unusual variations from year to year
and to get a more realistic final figure. When ties occurred in state
rates, the states involved were given the same rank.
U.S.
population data are from the U.S. Bureau of Census. The population of Puerto Rico age 13 and over was estimated
using total population data from the U.S. Bureau of the Census and the
projected age distributions from Eduard Bos, My T. Vu, Ernest Massiah,
and Rodolfo A. Bulatao, World population projections 1994-1995. Baltimore: Johns Hopkins Press, 1994, page 410.
|
| (3) |
The percentage of AIDS cases that are injection-related was calculated
by dividing the number of injection-related AIDS cases (the 3-year
average from the years 1996-1998) by the number of AIDS cases for which
the exposure group is known (also a 3-year average from the years
1996-1998). Each percent is rounded to the nearest 5.
Thus, for example, 42 percent was rounded to 40.
|
| (4) |
Injection-related AIDS rates per million for metro areas were calculated
using injection-related AIDS cases among persons age 13 and over (the
3-year average for the years 1996-1998) divided by the total 1997
population (including those age 12 and under). Population data are from
the U.S. Bureau of Census. When
ties occurred in rates, the metro areas involved were given the same
rank.
|
| (5) |
Injection-related AIDS rates per million by race/ethnic
group for each state were
calculated using injection-related AIDS cases among persons age 13 and over
for each racial/ethnic group (the
3-year average for the years 1996-1998) divided by the 1997 population
age 13 and over for that racial/ethnic group.
In instances when the ratio of AIDS rates for African Americans
to whites or Latinos to whites was greater than 20, the ratio is
reported as "greater than 20" rather than given as the exact
ratio. Rates are not reported when the total number of AIDS cases for
1996-1998 was less than 100.
|
| (6) |
Scott D. Holmberg, "The Estimated Prevalence and Incidence of HIV
in 96 Large US Metropolitan Areas," American Journal of Public
Health, May 1996, vol. 86, no. 5. Supplementary Material.
Available from the CDC.
|
For
other materials used on this website, see References.
|